Literature DB >> 24402712

When, how, and where can oral cholera vaccines be used to interrupt cholera outbreaks?

John Clemens1, Jan Holmgren.   

Abstract

Cholera continues to be a major global health problem, at times causing major and prolonged outbreaks in both endemic and nonendemic settings in developing countries. While improved water quality, sanitation, and hygiene (WASH) will provide the ultimate solution to prevention of this disease burden, this is a far-off goal for most developing countries. Oral cholera vaccines cholera vaccines (OCVs) have been demonstrated to be effective in the control of cholera outbreaks, and constitute useful tools to be used in conjunction with efforts to improve WASH. Two killed OCVs are prequalified by WHO for purchase by UN agencies for international use. Recently, WHO has launched a global stockpile stockpile of killed OCVs for use to control outbreaks. Rational deployment of OCV from this stockpile will require consideration of costs, feasibility, disease epidemiology epidemiology , and the protective characteristics of the vaccine deployed, as well as effective and rapid coordination of processes and logistics logistics used to make decisions on deployment and delivery of the vaccine to the population in need. Despite not having data on all the questions of relevance as to how to use OCVs to control cholera outbreaks in different settings, there is clearly more than enough evidence to initiate their use, as answers to remaining questions and refinement of policies will mainly come with experience.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24402712     DOI: 10.1007/82_2013_353

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  8 in total

1.  Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study.

Authors:  Dobromir T Dimitrov; Christopher Troeger; M Elizabeth Halloran; Ira M Longini; Dennis L Chao
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

2.  Development of stable Vibrio cholerae O1 Hikojima type vaccine strains co-expressing the Inaba and Ogawa lipopolysaccharide antigens.

Authors:  Stefan L Karlsson; Elisabeth Ax; Erik Nygren; Susanne Källgård; Margareta Blomquist; Annelie Ekman; John Benktander; Jan Holmgren; Michael Lebens
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

3.  Delivery cost analysis of a reactive mass cholera vaccination campaign: a case study of Shanchol™ vaccine use in Lake Chilwa, Malawi.

Authors:  Patrick G Ilboudo; Jean-Bernard Le Gargasson
Journal:  BMC Infect Dis       Date:  2017-12-19       Impact factor: 3.090

4.  Controlling cholera in the Ouest Department of Haiti using oral vaccines.

Authors:  Alexander Kirpich; Thomas A Weppelmann; Yang Yang; John Glenn Morris; Ira M Longini
Journal:  PLoS Negl Trop Dis       Date:  2017-04-14

5.  Cost-of-illness of cholera to households and health facilities in rural Malawi.

Authors:  Patrick G Ilboudo; Xiao Xian Huang; Bagrey Ngwira; Abel Mwanyungwe; Vittal Mogasale; Martin A Mengel; Philippe Cavailler; Bradford D Gessner; Jean-Bernard Le Gargasson
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

6.  Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach.

Authors:  Neisha Sundaram; Christian Schaetti; Sonja Merten; Christian Schindler; Said M Ali; Erick O Nyambedha; Bruno Lapika; Claire-Lise Chaignat; Raymond Hutubessy; Mitchell G Weiss
Journal:  BMC Public Health       Date:  2016-01-14       Impact factor: 3.295

7.  A prolonged, community-wide cholera outbreak associated with drinking water contaminated by sewage in Kasese District, western Uganda.

Authors:  Benon Kwesiga; Gerald Pande; Alex Riolexus Ario; Nazarius Mbona Tumwesigye; Joseph K B Matovu; Bao-Ping Zhu
Journal:  BMC Public Health       Date:  2017-07-18       Impact factor: 3.295

8.  Cost-effectiveness of a reactive oral cholera immunization campaign using Shanchol™ in Malawi.

Authors:  Patrick G Ilboudo; Martin A Mengel; Bradford D Gessner; Bagrey Ngwira; Philippe Cavailler; Jean-Bernard Le Gargasson
Journal:  Cost Eff Resour Alloc       Date:  2021-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.